Skip to Main Content

Paper Details

Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>).
J Med Chem
15
2016
Author NameAffiliation
Philip J R DayAstex Pharmaceuticals
  • 1 - 1

Datasets

Release 1.2